Literature DB >> 12624019

Molecular epidemiological analysis of Cryptosporidium isolates from humans and animals by using a heteroduplex mobility assay and nucleic acid sequencing based on a small double-stranded RNA element.

Francesca Leoni1, Chris I Gallimore, Jonathan Green, Jim McLauchlin.   

Abstract

Two extrachromosomal double-stranded RNA (dsRNA) elements occur in Cryptosporidium parvum. A heteroduplex mobility assay (HMA) was developed for the rapid characterization of sequence diversity in a 173-bp fragment of the small dsRNA element of Cryptosporidium with either a natural sequence from Cryptosporidium meleagridis or a synthetic sequence as reference DNA. The 173-bp fragment was generated from 265 samples of whole feces (242 from humans and 18 from livestock with C. parvum genotype 1 or 2, 4 from humans with Cryptosporidium felis, and 1 from a human with C. meleagridis). The HMA method identified 21 patterns in C. parvum (8 in genotype 1, 12 in genotype 2, and a type common to both genotypes), 4 patterns in C. felis, and 1 pattern in C. meleagridis. All patterns were confirmed as distinct by DNA sequencing. For genotype 1, a single HMA type was found in 89% of samples: 64 of 65 cases from three waterborne outbreaks, all 16 cases from eight intrafamilial outbreaks, and 17 of 28 sporadic cases. Among the remaining 11 sporadic cases due to genotype 1, seven other HMA types were detected. For genotype 2, a single HMA type was found in 72% of samples: 36 of 43 cases from three waterborne outbreaks, 11 of 15 cases from seven intrafamilial outbreaks, 44 of 75 sporadic cases, and all 18 samples from livestock. Within the intrafamilial outbreaks, two other HMA types were identified: the same HMA type was detected in samples from cases within the same outbreak. Among the sporadic cases due to genotype 2, 10 additional HMA types were detected.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12624019      PMCID: PMC150309          DOI: 10.1128/JCM.41.3.981-992.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  44 in total

Review 1.  Variation in Cryptosporidium: towards a taxonomic revision of the genus.

Authors:  U M Morgan; L Xiao; R Fayer; A A Lal; R C Thompson
Journal:  Int J Parasitol       Date:  1999-11       Impact factor: 3.981

2.  Genetic diversity within Cryptosporidium parvum and related Cryptosporidium species.

Authors:  L Xiao; U M Morgan; J Limor; A Escalante; M Arrowood; W Shulaw; R C Thompson; R Fayer; A A Lal
Journal:  Appl Environ Microbiol       Date:  1999-08       Impact factor: 4.792

3.  Virulence of three distinct Cryptosporidium parvum isolates for healthy adults.

Authors:  P C Okhuysen; C L Chappell; J H Crabb; C R Sterling; H L DuPont
Journal:  J Infect Dis       Date:  1999-10       Impact factor: 5.226

4.  Genetic characterization of Cryptosporidium strains from 218 patients with diarrhea diagnosed as having sporadic cryptosporidiosis.

Authors:  J McLauchlin; S Pedraza-Díaz; C Amar-Hoetzeneder; G L Nichols
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

5.  Molecular characterization of Cryptosporidium isolates obtained from human immunodeficiency virus-infected individuals living in Switzerland, Kenya, and the United States.

Authors:  U Morgan; R Weber; L Xiao; I Sulaiman; R C Thompson; W Ndiritu; A Lal; A Moore; P Deplazes
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

6.  Multilocus genotypic analysis of Cryptosporidium parvum isolates from different hosts and geographical origins.

Authors:  F Spano; L Putignani; A Crisanti; P Sallicandro; U M Morgan; S M Le Blancq; L Tchack; S Tzipori; G Widmer
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

7.  Genetic polymorphism at the beta-tubulin locus among human and animal isolates of Cryptosporidium parvum.

Authors:  S Cacciò; W Homan; K van Dijk; E Pozio
Journal:  FEMS Microbiol Lett       Date:  1999-01-01       Impact factor: 2.742

8.  New cryptosporidium genotypes in HIV-infected persons.

Authors:  N J Pieniazek; F J Bornay-Llinares; S B Slemenda; A J da Silva; I N Moura; M J Arrowood; O Ditrich; D G Addiss
Journal:  Emerg Infect Dis       Date:  1999 May-Jun       Impact factor: 6.883

9.  Differentiating human from animal isolates of Cryptosporidium parvum.

Authors:  I M Sulaiman; L Xiao; C Yang; L Escalante; A Moore; C B Beard; M J Arrowood; A A Lal
Journal:  Emerg Infect Dis       Date:  1998 Oct-Dec       Impact factor: 6.883

Review 10.  Genetic polymorphism among Cryptosporidium parvum isolates: evidence of two distinct human transmission cycles.

Authors:  M M Peng; L Xiao; A R Freeman; M J Arrowood; A A Escalante; A C Weltman; C S Ong; W R Mac Kenzie; A A Lal; C B Beard
Journal:  Emerg Infect Dis       Date:  1997 Oct-Dec       Impact factor: 6.883

View more
  4 in total

1.  Complete cryspovirus genome sequences from Cryptosporidium parvum isolate Iowa.

Authors:  Minh Vong; Jacob G Ludington; Honorine D Ward; Max L Nibert
Journal:  Arch Virol       Date:  2017-05-05       Impact factor: 2.574

2.  Structure of Fusarium poae virus 1 shows conserved and variable elements of partitivirus capsids and evolutionary relationships to picobirnavirus.

Authors:  Jinghua Tang; Wendy F Ochoa; Hua Li; Wendy M Havens; Max L Nibert; Said A Ghabrial; Timothy S Baker
Journal:  J Struct Biol       Date:  2010-07-03       Impact factor: 2.867

3.  Genetic characterization and transmission cycles of Cryptosporidium species isolated from humans in New Zealand.

Authors:  James J Learmonth; George Ionas; Kim A Ebbett; Errol S Kwan
Journal:  Appl Environ Microbiol       Date:  2004-07       Impact factor: 4.792

4.  Multilocus analysis of Cryptosporidium hominis and Cryptosporidium parvum isolates from sporadic and outbreak-related human cases and C. parvum isolates from sporadic livestock cases in the United Kingdom.

Authors:  Francesca Leoni; Marianne E Mallon; Huw V Smith; Andy Tait; Jim McLauchlin
Journal:  J Clin Microbiol       Date:  2007-08-08       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.